SPYH:F:F-SSgA SPDR ETFs Europe II Public Limited Company - SPDR MSCI Europe Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 227.3

Change

-2.95 (-1.28)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-7.46 (-1.28%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.20 (-0.39%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.87 (-1.51%)

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.05 (-0.35%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-1.32 (-1.27%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-6.25 (-2.60%)

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.22 (-2.84%)

USD 43.00B
0ZC:F Zscaler Inc

+7.08 (+4.05%)

USD 37.92B
BSND:F Danone SA

+0.40 (+2.94%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing SPYH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.36% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.36% 75% C 70% C-
Trailing 12 Months  
Capital Gain 7.47% 52% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.47% 49% F 49% F
Trailing 5 Years  
Capital Gain 48.21% 55% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.21% 55% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 9.52% 66% D+ 63% D
Dividend Return 9.52% 64% D 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.98% 76% C+ 94% A
Risk Adjusted Return 119.38% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike